Bridges Investment Management Has Raised Intel (INTC) Stake; Profile of 5 Analysts Covering Varian Medical Systems, Inc. (VAR)

Bridges Investment Management Inc increased Intel Corp (INTC) stake by 85.64% reported in 2017Q3 SEC filing. Bridges Investment Management Inc acquired 15,284 shares as Intel Corp (INTC)’s stock declined 2.96%. The Bridges Investment Management Inc holds 33,130 shares with $1.26M value, up from 17,846 last quarter. Intel Corp now has $230.68 billion valuation. The stock decreased 1.24% or $0.62 during the last trading session, reaching $49.29. About 35.54M shares traded or 2.66% up from the average. Intel Corporation (NASDAQ:INTC) has risen 19.47% since March 1, 2017 and is uptrending. It has outperformed by 2.77% the S&P500.

Among 12 analysts covering Varian Medical Systems Inc. (NYSE:VAR), 5 have Buy rating, 2 Sell and 5 Hold. Therefore 42% are positive. Varian Medical Systems Inc. had 37 analyst reports since August 27, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Friday, September 1 by RBC Capital Markets. As per Monday, July 24, the company rating was maintained by RBC Capital Markets. The stock has “Hold” rating by Robert W. Baird on Monday, August 28. The rating was initiated by RBC Capital Markets on Tuesday, December 22 with “Sector Perform”. The rating was maintained by Brean Capital on Thursday, April 28 with “Buy”. The stock has “Hold” rating by RBC Capital Markets on Thursday, November 30. Goldman Sachs downgraded the stock to “Sell” rating in Thursday, January 25 report. The rating was maintained by Jefferies on Wednesday, October 25 with “Buy”. Citigroup upgraded the stock to “Buy” rating in Monday, May 8 report. The rating was downgraded by Goldman Sachs on Monday, September 28 to “Sell”. See Varian Medical Systems, Inc. (NYSE:VAR) latest ratings:

25/01/2018 Broker: Robert W. Baird Rating: Hold New Target: $111.0 Maintain
25/01/2018 Broker: Barrington Rating: Buy New Target: $130.0 Upgrade
25/01/2018 Broker: JP Morgan Old Rating: Neutral New Rating: Neutral Old Target: $88 New Target: $105 Maintain
25/01/2018 Broker: RBC Capital Markets Rating: Hold New Target: $115.0 Maintain
25/01/2018 Broker: Citigroup Old Rating: Neutral New Rating: Buy Old Target: $128 New Target: $132 Maintain
25/01/2018 Broker: Goldman Sachs Rating: Sell New Target: $98.0 Downgrade
03/01/2018 Broker: Evercore Rating: Underperform New Target: $100 Initiates Coverage On
30/11/2017 Broker: RBC Capital Markets Rating: Hold New Target: $105.0 Maintain
30/10/2017 Broker: Citigroup Rating: Neutral Old Target: $119 New Target: $121 Maintain
26/10/2017 Broker: Robert W. Baird Rating: Hold New Target: $99.0 Maintain

Investors sentiment is 1.03 in Q3 2017. Its the same as in 2017Q2. It is the same, as 52 investors sold INTC shares while 663 reduced holdings. only 127 funds opened positions while 608 raised stakes. 3.05 billion shares or 0.19% more from 3.05 billion shares in 2017Q2 were reported. Proshare Advisors Ltd Liability Company holds 2.42M shares or 0.85% of its portfolio. Moreover, Wendell David Assocs Inc has 0.39% invested in Intel Corporation (NASDAQ:INTC). Franklin Res accumulated 21.80 million shares or 0.41% of the stock. Valley Natl Advisers reported 19,518 shares. Mycio Wealth Prtnrs Ltd Llc has 33,113 shares. Minnesota-based Bremer Natl Association has invested 1.02% in Intel Corporation (NASDAQ:INTC). Benedict Financial Inc holds 2.75% or 140,393 shares in its portfolio. Pictet Cie (Europe) Sa holds 0.05% or 9,900 shares. Rowland Investment Counsel Adv reported 4.38% stake. Foster Motley has invested 0.92% in Intel Corporation (NASDAQ:INTC). King Wealth Management Group Lc holds 0.29% in Intel Corporation (NASDAQ:INTC) or 20,215 shares. Kidder Stephen W has 2.55% invested in Intel Corporation (NASDAQ:INTC). Sky Investment Grp Limited Com, Connecticut-based fund reported 86,613 shares. Goodwin Daniel L holds 0.14% or 8,000 shares in its portfolio. Moreover, Acropolis Inv Mgmt Lc has 0.49% invested in Intel Corporation (NASDAQ:INTC).

Since October 2, 2017, it had 0 insider purchases, and 19 insider sales for $34.96 million activity. On Wednesday, February 21 McBride Kevin Thomas sold $31,943 worth of Intel Corporation (NASDAQ:INTC) or 686 shares. 17,946 Intel Corporation (NASDAQ:INTC) shares with value of $880,540 were sold by RENDUCHINTALA VENKATA S M. $267,663 worth of Intel Corporation (NASDAQ:INTC) was sold by Krzanich Brian M on Tuesday, January 23. 570 Intel Corporation (NASDAQ:INTC) shares with value of $25,360 were sold by Bryant Diane M. Shenoy Navin sold $436,410 worth of Intel Corporation (NASDAQ:INTC) on Friday, February 23. $3.99M worth of Intel Corporation (NASDAQ:INTC) was sold by BRYANT ANDY D. Another trade for 472,337 shares valued at $20.89M was made by Smith Stacy J on Monday, October 30.

Among 54 analysts covering Intel Corporation (NASDAQ:INTC), 36 have Buy rating, 5 Sell and 13 Hold. Therefore 67% are positive. Intel Corporation has $60.0 highest and $25 lowest target. $45.10’s average target is -8.50% below currents $49.29 stock price. Intel Corporation had 222 analyst reports since August 7, 2015 according to SRatingsIntel. Brean Capital maintained Intel Corporation (NASDAQ:INTC) on Wednesday, October 19 with “Buy” rating. Wedbush maintained the stock with “Outperform” rating in Monday, January 18 report. RBC Capital Markets maintained Intel Corporation (NASDAQ:INTC) rating on Friday, October 6. RBC Capital Markets has “Hold” rating and $40.0 target. The stock of Intel Corporation (NASDAQ:INTC) has “Buy” rating given on Monday, July 31 by Wells Fargo. Mizuho maintained it with “Buy” rating and $47.0 target in Tuesday, December 26 report. As per Tuesday, September 20, the company rating was initiated by Susquehanna. Canaccord Genuity maintained it with “Hold” rating and $41 target in Friday, October 27 report. The firm has “Neutral” rating by Goldman Sachs given on Wednesday, February 3. The firm has “Sell” rating given on Tuesday, October 3 by Jefferies. The firm has “Sector Perform” rating given on Tuesday, October 13 by RBC Capital Markets.

Investors sentiment increased to 1.02 in Q3 2017. Its up 0.07, from 0.95 in 2017Q2. It improved, as 37 investors sold Varian Medical Systems, Inc. shares while 166 reduced holdings. 51 funds opened positions while 156 raised stakes. 89.98 million shares or 0.15% less from 90.12 million shares in 2017Q2 were reported. Transamerica Fincl Advsr reported 7,665 shares. Eads Heald Invest Counsel reported 0.65% stake. United Capital Advisers Ltd holds 0.09% or 109,987 shares in its portfolio. Robecosam Ag invested in 0.02% or 2,300 shares. Quebec – Canada-based Fiera Cap has invested 1.15% in Varian Medical Systems, Inc. (NYSE:VAR). 5,300 are owned by North Star Asset Mgmt Inc. Tnb reported 1.4% stake. Edgestream Prtnrs Lp has invested 0.17% in Varian Medical Systems, Inc. (NYSE:VAR). Buckingham Asset Management Ltd Co has 2,351 shares. Baystate Wealth Mngmt Lc holds 0% or 20 shares. Croft stated it has 0.06% of its portfolio in Varian Medical Systems, Inc. (NYSE:VAR). Ajo Limited Partnership invested in 0.1% or 224,644 shares. Westport Asset Management holds 1,200 shares. Guardian Life Insur Of America accumulated 210 shares. Mason Street Advisors Ltd Limited Liability Company stated it has 0.03% of its portfolio in Varian Medical Systems, Inc. (NYSE:VAR).

Varian Medical Systems, Inc. designs, makes, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. The company has market cap of $10.90 billion. It operates through two divisions, Oncology Systems and Imaging Components. It has a 89.66 P/E ratio. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy.

The stock decreased 1.87% or $2.27 during the last trading session, reaching $119.34. About 677,026 shares traded. Varian Medical Systems, Inc. (NYSE:VAR) has risen 29.46% since March 1, 2017 and is uptrending. It has outperformed by 12.76% the S&P500.